טוען...
Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis
OBJECTIVE: To compare the relationship between clinical measures and patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA) treated with tofacitinib or methotrexate (MTX). METHODS: In a phase 3 randomised controlled trial, patients (N=956) who were MTX-naïve or had received ≤3 d...
שמור ב:
| הוצא לאור ב: | RMD Open |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4860866/ https://ncbi.nlm.nih.gov/pubmed/27175296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2015-000232 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|